Nasal absorption of growth hormone in normal subjects: studies with four different formulations.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

A closer imitation of this pattern might be achieved by administering GH nasally.

Who Took Part

The age groups tagged for this paper are adults, both men and women.

Participants were admitted to the hospital during the four study periods.

During the study the subjects completed a questionnaire to record nasal symptoms.

How the Study Was Run

The researchers set it up as a randomized and double-blind study.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.

Anterior rhinoscopy was performed at 0 and 4 h.

Sixteen healthy subjects were examined at 0800 h after an overnight fast.

What Was Measured

PubMed files the paper under topics including Absorption, Growth Hormone, Nasal Mucosa and Phosphatidylcholines.

What This Means in Plain Language

The paper is a randomized and double-blind study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Its findings take up roughly 9 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 1994 (The Annals of pharmacotherapy), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.